Biotek-snakken — Juni 2018
-
Det er ikke utænkeligt at Zyme, vil præsentere part 3. for zw25 på ESMO evt. som latebreaker, i givet positiv fald, vil det kunne være en stor tricker.https://www.clinicaltrials.gov/ct2/results?cond=&term=zw25&cntry=&state=&city=&dist=
-
-
Nu rykker Nuevolution på ho
vedbørs. Mon ikke det tiltrækker flere investorer. -
Nye rygter om Roche interesse i opkøb af TSRO giver aktien et tiltrængt løft https://seekingalpha.com/news/3365148-tesaro-7-percent-premarket-reported-roche-bid?app=1&dr=1#email_link
-
-
Citi holder fast på hold på Zyme https://www.smarteranalyst.com/brief/citigroup-reaffirms-their-hold-rating-on-zymeworks-inc/
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind